Ignite Creation Date:
2024-05-06 @ 1:11 PM
Last Modification Date:
2024-10-26 @ 1:10 PM
Study NCT ID:
NCT03954405
Status:
RECRUITING
Last Update Posted:
2021-04-13
First Post:
2019-05-10
Brief Title:
Multi-marker Approach for Risk Assessment in PAH
Sponsor:
Wuhan Asia Heart Hospital
Organization:
Wuhan Asia Heart Hospital
Study Overview
Official Title:
Multi-marker Approach for Risk Assessment in Pulmonary Arterial Hypertension PAH
Status:
RECRUITING
Status Verified Date:
2021-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MARS
Brief Summary:
Prospective registry including incident patients and prevalent patients which pretends to identify clinical characteristics treatment trends in-hospital and ten years follow-up outcome through major adverse cardiovascular events MACE in a China population with well characterized PAH
Detailed Description:
baseline include An echocardiogram to assess the size shape pumping action and the extent of any damage to the heart
Lung function tests which include blowing measurements to assess gas volumes within the lungs as well as assessment of how the lungs exchange gases
Right heart catheterisation RHC to diagnose PAH Optional Cardiac Magnetic Resonance tests 6 minute walk distance 6MWD To measure exercise capacity Electrocardiogram ECG a test that measures the electrical activity of the heart Blood tests
MACE include
death heartlung transplantation atrial septostomy hospitalization due to worsening of PAH start of new specific PAH treatment persistent decrease of 15 from baseline in 6MWD or 30 compared with last study-related measurement persistent worsening of World Health Organization WHO Functional Class FC
Lung function tests which include blowing measurements to assess gas volumes within the lungs as well as assessment of how the lungs exchange gases
Right heart catheterisation RHC to diagnose PAH Optional Cardiac Magnetic Resonance tests 6 minute walk distance 6MWD To measure exercise capacity Electrocardiogram ECG a test that measures the electrical activity of the heart Blood tests
MACE include
death heartlung transplantation atrial septostomy hospitalization due to worsening of PAH start of new specific PAH treatment persistent decrease of 15 from baseline in 6MWD or 30 compared with last study-related measurement persistent worsening of World Health Organization WHO Functional Class FC
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None